VCNX
Vaccinex, Inc.
OTCHealthcareBiotechnologyUS
Company Profile
CEO
Maurice Zauderer
IPO Date
2018-08-09
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Vaccinex, Inc.
CEO
Maurice Zauderer
IPO Date
2018-08-09
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 584,646 |
| $0.00 |
| 18 Nov 2024 | Zauderer Maurice | director, 10 percent owner, officer: President and CEO | A-Award | Acquired | 46,153 | $3.25 |
| 20 Sept 2024 | FRIEDBERG ALBERT | director, 10 percent owner: | M-Exempt | Acquired | 25,723 | $5.64 |
| 20 Sept 2024 | FRIEDBERG ALBERT | director, 10 percent owner: | M-Exempt | Acquired | 214,286 | $5.64 |
| 20 Sept 2024 | FRIEDBERG ALBERT | director, 10 percent owner: | A-Award | Acquired | 653,210 | $5.64 |
| 20 Sept 2024 | FRIEDBERG ALBERT | director, 10 percent owner: | M-Exempt | Disposed | 25,723 | $0.00 |
| 20 Sept 2024 | FRIEDBERG ALBERT | director, 10 percent owner: | M-Exempt | Disposed | 214,286 | $5.64 |
| 20 Sept 2024 | Zauderer Maurice | director, 10 percent owner, officer: President and CEO | M-Exempt | Acquired | 35,715 | $5.64 |
| 20 Sept 2024 | Zauderer Maurice | director, 10 percent owner, officer: President and CEO | M-Exempt | Acquired | 9,768 | $5.64 |